×
Entrez Id:
5781
Gene Symbol:
PTPN11
PTPN11
Noonan Syndrome
1.000
Biomarker
GENOMICS_ENGLAND
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
Noonan Syndrome
0.780
Biomarker
GENOMICS_ENGLAND
×
Entrez Id:
5604
Gene Symbol:
MAP2K1
MAP2K1
Noonan Syndrome
0.680
GeneticVariation
CLINVAR
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Noonan Syndrome
0.640
Biomarker
CLINGEN
×
Entrez Id:
5500
Gene Symbol:
PPP1CB
PPP1CB
Noonan Syndrome
0.350
Biomarker
CLINGEN
×
Entrez Id:
317
Gene Symbol:
APAF1
APAF1
Noonan Syndrome
0.200
Biomarker
MGD
×
Entrez Id:
55835
Gene Symbol:
CENPJ
CENPJ
Noonan Syndrome
0.200
Biomarker
MGD
×
Entrez Id:
545
Gene Symbol:
ATR
ATR
Noonan Syndrome
0.200
Biomarker
MGD
×
Entrez Id:
80254
Gene Symbol:
CEP63
CEP63
Noonan Syndrome
0.200
Biomarker
MGD
×
Entrez Id:
6654
Gene Symbol:
SOS1
SOS1
Noonan Syndrome
1.000
CausalMutation
CLINVAR
[Observations on cancer metastasis from an unknown primary location].
1758637
1991
×
Entrez Id:
5894
Gene Symbol:
RAF1
RAF1
Noonan Syndrome
1.000
GeneticVariation
CLINVAR
Downgrading of arts-centered education in state schools.
1760348
1992
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Noonan Syndrome
1.000
GeneticVariation
CLINVAR
Probing the role of loop 2 in Ras function with unnatural amino acids.
8234268
1993
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Noonan Syndrome
1.000
GeneticVariation
CLINVAR
Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
8246952
1993
×
Entrez Id:
4763
Gene Symbol:
NF1
NF1
Noonan Syndrome
0.350
GeneticVariation
BEFREE
Here we provide evidence for the former by demonstrating a mutation in the NF1 gene in a family with features of both WS and NS .
8317503
1993
×
Entrez Id:
7391
Gene Symbol:
USF1
USF1
Noonan Syndrome
0.010
GeneticVariation
BEFREE
Between January 2, 1982 and December 31, 1997 through the USF Regional Genetics Program we evaluated 566 propositi with suspected or clinically diagnosed neurofibromatosis (NF1, NF2, segmental NF=NF5, NF/Noonan syndrome , familial café-au-lait macules, and solitary neurofibroma, NF).
10528238
1999
×
Entrez Id:
4893
Gene Symbol:
NRAS
NRAS
Noonan Syndrome
0.780
CausalMutation
CLINVAR
Juvenile myelomonocytic leukemia and Noonan syndrome.
10598665
2000
×
Entrez Id:
6655
Gene Symbol:
SOS2
SOS2
Noonan Syndrome
0.620
Biomarker
CLINGEN
Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development.
10938118
2000
×
Entrez Id:
6655
Gene Symbol:
SOS2
SOS2
Noonan Syndrome
0.620
Biomarker
GENOMICS_ENGLAND
Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development.
10938118
2000
×
Entrez Id:
6128
Gene Symbol:
RPL6
RPL6
Noonan Syndrome
0.010
Biomarker
BEFREE
RPL6 was mapped to chromosome 12q24.1 between the markers D12S84 and D12S861, which is in the critical region for Noonan syndrome .
11043511
2000
×
Entrez Id:
1840
Gene Symbol:
DTX1
DTX1
Noonan Syndrome
0.010
Biomarker
BEFREE
The DTX1 gene maps to chromosomal region 12q24 in the vicinity of the Noonan syndrome critical region.
11153911
2000
×
Entrez Id:
6654
Gene Symbol:
SOS1
SOS1
Noonan Syndrome
1.000
GeneticVariation
CLINVAR
Structure-based mutagenesis reveals distinct functions for Ras switch 1 and switch 2 in Sos-catalyzed guanine nucleotide exchange.
11333268
2001
×
Entrez Id:
5781
Gene Symbol:
PTPN11
PTPN11
Noonan Syndrome
1.000
AlteredExpression
BEFREE
This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.
11704759
2001
×
Entrez Id:
5781
Gene Symbol:
PTPN11
PTPN11
Noonan Syndrome
1.000
CausalMutation
CLINVAR
This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.
11704759
2001
×
Entrez Id:
5781
Gene Symbol:
PTPN11
PTPN11
Noonan Syndrome
1.000
Biomarker
CLINGEN
This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.
11704759
2001
×
Entrez Id:
5781
Gene Symbol:
PTPN11
PTPN11
Noonan Syndrome
1.000
GeneticVariation
CLINVAR
This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.
11704759
2001